Literature DB >> 19796509

Determination of trace cantharidin in plasma and pharmacokinetic study in beagle dogs using gas chromatography-mass spectrometry.

Yun-Jie Dang1, Chun-Yan Zhu.   

Abstract

The blister beetle is traditional Chinese medicine that was first discovered and used as anticancer drug in China, and cantharidin proved to be its principal active ingredient. Cantharidin-based pharmaceutical preparations are now widely used in clinics in China with good therapeutic efficacy. As a toxic anticancer drug, the therapeutic dose of cantharidin is low, and no method to determine the blood cantharidin concentration under the therapeutic dose has so far been reported. Here, we present a simple, sensitive, and reliable gas chromatography-mass spectrometry (GC-MS) method to monitor the plasma cantharidin and perform the pharmacokinetic study of cantharidin in beagle dogs. After protein precipitation by hydrochloric acid, a liquid-liquid extraction procedure using ethyl acetate was applied to extract cantharidin from plasma. An elastic quartz capillary GC column DB-5MS was used in GC-MS, the temperature was kept at 60 degrees C for 1 min, then increased to 220 degrees C at the rate of 6 degrees C/min, held there for 1 min, and then to 280 degrees C at the rate of 20 degrees C/min, held for 3 min. The extraction recovery was over 80% for all the tested specimens. The linearity ranged from 2.14 to 314.2 ng/mL, the intra- and interday precisions were both below 20%, the limit of detection was 0.5 ng/mL, and the limit of quantification was 2.14 ng/mL. Cantharidin in plasma proved to be stable during the whole period of storage, treatment, and analysis. Cantharidin demonstrated as one-compartment model after i.v. administration with an elimination half-life of 0.69 +/- 0.03 h and area under curve of 204 +/- 24 h.ng/mL. This GC-MS assay proved to have high precision, accuracy, reliability, and sensitivity, and it was suitable for determination of trace cantharidin in plasma.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19796509     DOI: 10.1093/jat/33.7.384

Source DB:  PubMed          Journal:  J Anal Toxicol        ISSN: 0146-4760            Impact factor:   3.367


  5 in total

1.  Oral bioavailability of cantharidin-loaded solid lipid nanoparticles.

Authors:  Yun-Jie Dang; Chun-Yan Zhu
Journal:  Chin Med       Date:  2013-01-08       Impact factor: 5.455

2.  Liquid chromatography-tandem mass spectrometry (LC-MS/MS) determination of cantharidin in biological specimens and application to postmortem interval estimation in cantharidin poisoning.

Authors:  Youyou Zhang; Liang Liu; Liang Ren
Journal:  Sci Rep       Date:  2020-06-26       Impact factor: 4.379

3.  Induction of Suicidal Erythrocyte Death by Cantharidin.

Authors:  Kousi Alzoubi; Jasmin Egler; Marilena Briglia; Antonella Fazio; Caterina Faggio; Florian Lang
Journal:  Toxins (Basel)       Date:  2015-07-28       Impact factor: 4.546

Review 4.  Recent advances in oral delivery of drugs and bioactive natural products using solid lipid nanoparticles as the carriers.

Authors:  Chih-Hung Lin; Chun-Han Chen; Zih-Chan Lin; Jia-You Fang
Journal:  J Food Drug Anal       Date:  2017-03-14       Impact factor: 6.157

5.  Cantharidin inhibits osteosarcoma proliferation and metastasis by directly targeting miR-214-3p/DKK3 axis to inactivate β-catenin nuclear translocation and LEF1 translation.

Authors:  Shaopu Hu; Junli Chang; Hongfeng Ruan; Wenlan Zhi; Xiaobo Wang; Fulai Zhao; Xiaoping Ma; Xingyuan Sun; Qianqian Liang; Hao Xu; Yongjun Wang; Yanping Yang
Journal:  Int J Biol Sci       Date:  2021-06-16       Impact factor: 6.580

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.